RNA Manufacturing Spotlight at World Vaccine Congress

uBriGene Biosciences is proud to announce our participation in the upcoming 25th World Vaccine Congress Washington, taking place April 22–24, 2025, at the Walter E. Washington Convention Center in Washington, D.C. As one of the most influential and anticipated global events in vaccine development, this year’s Congress will bring together over 4,500 leaders and innovators from across the biopharmaceutical industry.

We invite you to connect with us at Booth #691, where our team of experts will be on-site to showcase uBriGene’s robust RNA-LNP Contract Research, Development, and Manufacturing Organization (CRDMO) capabilities. With a growing demand for RNA-based therapeutics, we’re excited to highlight how our comprehensive services are empowering biotech and pharma innovators worldwide.

Discover Our RNA-LNP CRDMO Capabilities
uBriGene will showcase our end-to-end RNA-LNP CRDMO capabilities designed to accelerate RNA therapeutic development. Our offerings include GMP-compliant manufacturing of mRNA, circular RNA (circRNA), and self-amplifying RNA (saRNA), alongside advanced lipid nanoparticle (LNP) formulation for efficient RNA delivery. Guided by our core values—quality, efficiency, innovation, integrity, and scalability—we support partners from early-stage research through clinical-scale production with a fully integrated platform built for success.

Join Us at the Expo Showcase
As part of the official Expo Showcase, uBriGene will be delivering a presentation titled: “Innovative Manufacturing of RNA Vaccines” at 11:00 AM on April 23rd, 2025, at the Exhibition Showcase stage

This presentation will explore scalable RNA vaccine production strategies, optimized process workflows, and the integration of quality and speed to accelerate delivery from bench to bedside.

Explore Our Poster Session
We are also excited to present a featured poster during the scientific poster session: “Quality Control Methods for Circular RNA Purity and Integrity” everyday at 2:00 PM, April 22 - 24, at the Poster Zone

This poster will dive into our latest innovations in analytical methods for circular RNA, a promising modality in the evolving RNA therapeutics landscape. We’ll share insights on assessing purity, structure, and integrity — all critical to ensuring product consistency and therapeutic efficacy.

Let’s Connect in Washington, D.C.
The World Vaccine Congress provides a dynamic platform for learning, collaboration, and networking. With leading experts from across research, clinical development, regulatory, and manufacturing, it’s the ideal venue to share ideas and spark innovation.

Whether you’re looking for a trusted CDMO partner, have questions about RNA manufacturing, or just want to learn more about emerging technologies — the uBriGene team is ready to connect.

📍 Booth #691
📅 April 22–24, 2025
📌 Walter E. Washington Convention Center, Washington, D.C.

To learn more about the event, visit the official website: World Vaccine Congress